AO "APTEKA N 26", Mari El Republic

Economic indicators

Net loss (RA) of AO APTEKA N 26 made up 339.00 thousand RUB over 2024 compared to net profit of 30.00 thousand RUB over 2023, the company informed.

Revenue decreased in the accounting period by 14.90% to 8.31 million RUB from 9.77 million RUB in 2023; cost of goods sold decreased by 16.10% to 6.03 million RUB from 7.19 million RUB; sales loss grew 4.52 times to 371.00 thousand RUB from 82.00 thousand RUB.

Net profit (RAS) of AO APTEKA N 26 dropped in 2023 2.07 times to 30.00 thousand RUB from 62.00 thousand RUB over the same period in 2022, the company informed.

Revenue increased in the accounting period by 5.50% to 9.77 million RUB from 9.26 million RUB over 2022; cost of goods sold grew by 6.66% to 7.19 million RUB from 6.74 million RUB; sales loss decreased by 2.38% to 82.00 thousand RUB from 84.00 thousand RUB.

Net profit (RAS) of AO APTEKA N 26 made up 62.00 thousand RUB over 2022 compared to net loss of 286.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 1.50% to 9.26 million RUB from 9.40 million RUB in 2021; cost of goods sold decreased by 2.62% to 6.74 million RUB from 6.92 million RUB; sales loss decreased 2.57 times to 84.00 thousand RUB from 216.00 thousand RUB.

Net loss (RA) of AO APTEKA N 26 made up 286.00 thousand RUB over 2021 compared to net profit of 13.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 6.31% to 9.40 million RUB from 10.03 million RUB in 2020; cost of goods sold decreased by 6.07% to 6.92 million RUB from 7.37 million RUB; sales loss made up 216.00 thousand RUB compared to sales profit of 34.00 thousand RUB.

Net profit (RAS) of AO APTEKA N 26 grew over 2020 1.86 times to 13.00 thousand RUB from 7.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period by 4.13% to 10.03 million RUB from 9.63 million RUB over 2019; cost of goods sold grew by 3.79% to 7.37 million RUB from 7.10 million RUB; sales profit made up 34.00 thousand RUB compared to sales loss of 183.00 thousand RUB.

Net profit (RAS) of AO APTEKA N 26 made up 7.00 thousand RUB over 2019 compared to net loss of 135.00 thousand RUB over 2018, the company informed.

Revenue decreased in the accounting period by 2.00% to 9.63 million RUB from 9.83 million RUB in 2018; cost of goods sold decreased by 1.92% to 7.10 million RUB from 7.24 million RUB; sales loss grew 2.61 times to 183.00 thousand RUB from 70.00 thousand RUB.

Net loss (RA) of AO APTEKA N 26 made up 135.00 thousand RUB over 2018 compared to net profit of 36.00 thousand RUB over 2017, the company informed.

Revenue decreased in the accounting period by 13.43% to 9.83 million RUB from 11.36 million RUB in 2017; cost of goods sold decreased by 15.73% to 7.24 million RUB from 8.59 million RUB; sales loss made up 70.00 thousand RUB compared to sales profit of 86.00 thousand RUB.

Net profit (RAS) of AO APTEKA N 26 dropped in 2017 4.67 times to 36.00 thousand RUB from 168.00 thousand RUB over the same period in 2016, the company informed.

Revenue decreased in the accounting period by 2.10% to 11.36 million RUB from 11.60 million RUB in 2016; cost of goods sold decreased by 2.95% to 8.59 million RUB from 8.85 million RUB; sales profit fell by 47.56% to 86.00 thousand RUB from 164.00 thousand RUB.

Net profit (RAS) of AO APTEKA N 26 grew over 2016 5.25 times to 168.00 thousand RUB from 32.00 thousand RUB over 2015, the company informed.

Revenue increased in the accounting period 4.06 times to 11.60 million RUB from 2.86 million RUB over 2015; cost of goods sold grew 4.11 times to 8.85 million RUB from 2.15 million RUB; sales profit went up 2.22 times to 164.00 thousand RUB from 74.00 thousand RUB.

Companies in the region

• APIMILK
• APEL'SIN
• APGREYD
• ANTEY-LOGISTIK
• ANTEY